Antoine Tarral

1.2k total citations
29 papers, 560 citations indexed

About

Antoine Tarral is a scholar working on Epidemiology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Antoine Tarral has authored 29 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 7 papers in Pharmacology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Antoine Tarral's work include Trypanosoma species research and implications (8 papers), Research on Leishmaniasis Studies (7 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Antoine Tarral is often cited by papers focused on Trypanosoma species research and implications (8 papers), Research on Leishmaniasis Studies (7 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Antoine Tarral collaborates with scholars based in France, Switzerland and Italy. Antoine Tarral's co-authors include Henri Merdjan, Manickam Rangaraju, Nathalie Strub‐Wourgaft, Olaf Valverde Mordt, Shampa Das, F. Jehl, H. Monteil, Jianguo Li, Séverine Blesson and Virginie Gualano and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Psychopharmacology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Antoine Tarral

29 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antoine Tarral France 14 204 169 130 121 66 29 560
Erkki Palva Finland 14 200 1.0× 74 0.4× 38 0.3× 102 0.8× 80 1.2× 34 630
Jennifer Carnell United States 11 158 0.8× 139 0.8× 287 2.2× 35 0.3× 42 0.6× 22 805
Carolyn M. Myers United States 20 175 0.9× 416 2.5× 187 1.4× 39 0.3× 48 0.7× 40 870
Sonia L. Minassian United States 12 106 0.5× 189 1.1× 82 0.6× 88 0.7× 323 4.9× 19 1.0k
Eric Shore United States 15 336 1.6× 259 1.5× 208 1.6× 15 0.1× 165 2.5× 23 930
Jean‐Paul Soucy Canada 13 134 0.7× 58 0.3× 105 0.8× 71 0.6× 102 1.5× 36 810
Giuseppe Pontrelli Italy 16 184 0.9× 30 0.2× 49 0.4× 95 0.8× 99 1.5× 34 807
Anu Gupta India 14 116 0.6× 39 0.2× 37 0.3× 58 0.5× 121 1.8× 89 581
Liwen Xi United States 11 232 1.1× 626 3.7× 107 0.8× 28 0.2× 126 1.9× 13 1.3k
Pirkko Paakkari Finland 12 126 0.6× 93 0.6× 58 0.4× 150 1.2× 31 0.5× 26 684

Countries citing papers authored by Antoine Tarral

Since Specialization
Citations

This map shows the geographic impact of Antoine Tarral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoine Tarral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoine Tarral more than expected).

Fields of papers citing papers by Antoine Tarral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoine Tarral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoine Tarral. The network helps show where Antoine Tarral may publish in the future.

Co-authorship network of co-authors of Antoine Tarral

This figure shows the co-authorship network connecting the top 25 collaborators of Antoine Tarral. A scholar is included among the top collaborators of Antoine Tarral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoine Tarral. Antoine Tarral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lejon, Veerle, Erick Mwamba Miaka, Dieudonné Mumba Ngoyi, et al.. (2025). The STROGHAT study protocol: An intervention study to evaluate safety, effectiveness and feasibility of treating gambiense HAT seropositive subjects with acoziborole.. Open Research Europe. 5. 23–23. 1 indexed citations
2.
Tarral, Antoine, Thierry Duvauchelle, Yves Donazzolo, et al.. (2023). Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study. Clinical Pharmacokinetics. 62(3). 481–491. 7 indexed citations
3.
Reet, Nick Van, Dieudonné Mumba Ngoyi, Erick Mwamba Miaka, et al.. (2022). Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study. EBioMedicine. 86. 104376–104376. 3 indexed citations
4.
Reet, Nick Van, Dieudonné Mumba Ngoyi, Erick Mwamba Miaka, et al.. (2021). Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection. PLoS neglected tropical diseases. 15(9). e0009739–e0009739. 7 indexed citations
5.
Alvar, Jorge, Fabiana Alves, Bruno Bucheton, et al.. (2020). Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases. Seminars in Immunopathology. 42(3). 231–246. 36 indexed citations
6.
Watson, James A, et al.. (2019). Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole. Antimicrobial Agents and Chemotherapy. 63(4). 19 indexed citations
7.
Tarral, Antoine & Henri Merdjan. (2015). Effect of Age and Sex on the Pharmacokinetics and Safety of Avibactam in Healthy Volunteers. Clinical Therapeutics. 37(4). 877–886. 24 indexed citations
8.
9.
Civelli, Maurizio, Alessandro Preti, Valentina Cenacchi, et al.. (2007). Single and multiple ascending dose studies of a novel tissue‐selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women. British Journal of Clinical Pharmacology. 64(3). 304–316. 4 indexed citations
10.
Astruc, B, et al.. (2005). Steady‐state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects. British Journal of Clinical Pharmacology. 59(4). 405–414. 3 indexed citations
11.
Allain, H., et al.. (2003). Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Psychopharmacology. 165(4). 419–429. 24 indexed citations
12.
Tarral, Antoine, et al.. (2003). Safety, Pharmacokinetics, and Pharmacodynamics of CHF 3381, a Novel N‐Methyl‐D‐Aspartate Antagonist, after Single Oral Doses in Healthy Subjects. The Journal of Clinical Pharmacology. 43(8). 901–911. 5 indexed citations
13.
14.
Tarral, Antoine, et al.. (1997). Effects of Terbinafine on the Pharmacokinetics of Digoxin in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(4). 791–795. 7 indexed citations
15.
Emre, Murat, et al.. (1996). Effects of the novel NMDA-receptor antagonist SDZ EAA 494 on memory and attention in humans. Psychopharmacology. 124(3). 261–266. 27 indexed citations
16.
Loisance, D, et al.. (1993). Pharmacological bridge to cardiac transplantation: Current limitations. The Annals of Thoracic Surgery. 55(1). 310–313. 11 indexed citations
17.
Tarral, Antoine, et al.. (1990). Effects of enoximone on quality of life. International Journal of Cardiology. 28. S29–S32. 19 indexed citations
18.
Loisance, D, Philippe Deleuze, Anne-Marie Duval, et al.. (1989). Pharmacological bridge to cardiac transplantation. European Journal of Cardio-Thoracic Surgery. 3(3). 196–202. 15 indexed citations
19.
Loisance, D, et al.. (1988). Enoximone, a pharmacological bridge to transplantation.. PubMed. 64. 73–9. 6 indexed citations
20.
Jehl, F., Antoine Tarral, Umberto Siméoni, et al.. (1988). Pharmacokinetics of teicoplanin in children. Journal of Antimicrobial Chemotherapy. 21(suppl A). 47–51. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erkki Palva Breakdown of academic impact, for papers by Jennifer Carnell Breakdown of academic impact, for papers by Carolyn M. Myers Breakdown of academic impact, for papers by Sonia L. Minassian Breakdown of academic impact, for papers by Eric Shore Breakdown of academic impact, for papers by Jean‐Paul Soucy Breakdown of academic impact, for papers by Giuseppe Pontrelli Breakdown of academic impact, for papers by Anu Gupta Breakdown of academic impact, for papers by Liwen Xi Breakdown of academic impact, for papers by Pirkko Paakkari
Rankless by CCL
2026